Navigation Links
Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Date:8/19/2007

s or delays in the implementation of the Company's strategies that may adversely affect the Company's continued commercialization of its PCT Sample Preparation System; the Company's financial results for the three and six months ended June 30, 2007 may not necessarily be indicative of future results as future revenues may not meet expectations due to the possible failure of the Company's products to achieve commercial acceptance, changes in customers needs and technological innovations, and expenses that may be higher than anticipated due to unforeseen cost increases; if the Company's expenses are higher than anticipated or if the Company's revenues do not increase, the Company may not have sufficient cash to support its planned activities and the Company may be unable to obtain financing on acceptable terms; the Company may not be successful in developing its external sales force; the new PCT-dependent method of protein extraction from lipid-rich samples may not offer any advantages over current methods of protein extraction and may not be adopted by the scientific community; the Company's new ProteoSolve kit may not achieve commercial acceptance; and the Company may be unable to develop new PCT-related products that achieve commercial acceptance. Additional risks and uncertainties that could cause actual results to differ materially from those indicated by these forward-looking statements are discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007, in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Visit us at our website http://www.pressurebiosciences.com

Investor Contacts:

Richa
'/>"/>

SOURCE Pressure BioSciences, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. The Analysis of Polycyclic Aromatic Hydrocarbons (PAHs) by LC/MS/MS Using an Atmospheric Pressure Photoionization Source
2. Determination of N-nitrosamines in Baby Bottle Rubber Teats by Liquid Chromatography-Atmospheric Pressure Chemical Ionization Mass Spectrometry
3. Screening of Corticosteroids in Urine by Negative Atmospheric Pressure Chemical Ionization LC/MS/MS
4. Medical College receives $11 million grant to study high blood pressure
5. Pressure mounts for Doyle to repeal shareholder liability law
6. Probe into gas gouging may educate Americans about pressures on oil supply
7. SWIB gets more pressure to invest in state tech start-ups
8. Technology puts pressure on old education methods
9. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
10. Sonic Foundry reports GAAP loss as Q2 revenues rise
11. Fiserv reports $113.5 million in Q1 profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 DTS Language ... its Online Web Portal for Life Science organizations who need ... specify the subject matter of their documents in advance with ... help reduce time-to-delivery of translations, often a critical factor in ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. – ... Warrington, Pa. , Details: The Hepatitis B Foundation, ... cure for hepatitis B and improving the quality of life ... on Friday, April 11 at Warrington Country Club in Warrington, ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, ... is an emerging biomedical company acquiring, developing, manufacturing, and ... , Free report download: http://equitiesiq.com/reports/alliqua/ , In ... team and Board, which launched the company’s new strategy ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Milwaukee, Wis. - A cardiac surgery team led by ... a temporary total artificial heart at Aurora St. Luke's ... been among the first to introduce this new technology to ... program, in a release. , ,The Madison-area patient, who was ...
... arrangement, an area producer of ingredients for drug candidates ... , Scientific Protein Laboratories, LLC , a producer of ... has been purchased by the publicly traded buyout firm ... ,American Capital's significant capital resources will be utilized to ...
... - The United States Catholic Bishops did not waver, ... White House . , , Wisconsin Right to Life , ... of deriving stem cells from human embryos that does not destroy ... promising development. , ,While various objections still remain, could the fact ...
Cached Biology Technology:Protein lab could prosper under new owner 2There's a new dynamic in the stem cell debate 2There's a new dynamic in the stem cell debate 3There's a new dynamic in the stem cell debate 4
(Date:4/17/2014)... in France have hit on a novel method ... the correct and most effective treatment possible., Kidney ... western and developing world. If left untreated, apart ... renal failure and other complications. In many patients ... Clearly a more effective pathological approach to diagnosis ...
(Date:4/17/2014)... the Cell Press journal Current Biology on ... novel sex lives. The Brazilian insects, which represent four ... , are the first example of an animal with ... identified in several different animals, Neotrogla is ... also reversed," says Kazunori Yoshizawa from Hokkaido University in ...
(Date:4/17/2014)... at the University of Texas Medical Branch at ... women treated with radiation for cervical cancer should ... , The UTMB researchers, finding a high ... survivors treated with radiation, offer new recommendations that ... cancer screening about eight years after their initial ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2
... Spanish . , Contributing to the diversity ... or a few species); using examples of native flora preferably ... in the design of landscaped areas are some of the ... a low-allergy impact. That is the opinion of Paloma ...
... CA -- A link between the immune system and ... of obsolete or toxic parts may one day yield ... deadly infectious diseases. Scientists with the U.S. Department of ... discovered proteins residing in both systems that point to ...
... New York (Sept. 21, 2008) A study in ... describes the function and interaction of a critical ... These new findings reveal that blocking this molecule, called ... may be viable therapeutic strategies for the prevention and ...
Cached Biology News:Expert recommends town councils to design low-allergy impact green spaces 2Proteomics study yields clues as to how tuberculosis might be thwarting the immune system 2Proteomics study yields clues as to how tuberculosis might be thwarting the immune system 3Mitochondria could be a target for therapeutic strategy for Alzheimer's disease patients 2
Rabbit anti Mouse ZIC2 Preservative: NaN3...
Chicken Anti-Human Stomatin-like 2 (STOML2 Polyclonal AntibodyNew Applications: ELISA, Western Blot...
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
... Antibody to Asb-2 (Ankyrin repeat and SOCS ... against synthetic peptides containing amino acids 75-93 ... spleen lysate (Imgenex Catalog No. 40149) can ... should cross react with mouse and rat ...
Biology Products: